2023
Martin, Laurent F, et al. “Green Light Exposure Elicits Anti-Inflammation, Endogenous Opioid Release and Dampens Synaptic Potentiation to Relieve Post-Surgical Pain.”. J Pain, vol. 24, no. 3, Mar. 2023, pp. 509-2, https://doi.org/10.1016/j.jpain.2022.10.011.
Tina Navaei, et al. “Investigation of the Impact of Bacterial Microencapsulation on Natural Product Discovery”. Science Direct, vol. Volume 6, Mar. 2023.
Yin, Fei. “Lipid Metabolism and Alzheimer’s Disease: Clinical Evidence, Mechanistic Link and Therapeutic Promise.”. FEBS J, vol. 290, no. 6, Mar. 2023, pp. 1420-53, https://doi.org/10.1111/febs.16344.
Mi, Yashi, et al. “Loss of Fatty Acid Degradation by Astrocytic Mitochondria Triggers Neuroinflammation and Neurodegeneration.”. Nat Metab, vol. 5, no. 3, Mar. 2023, pp. 445-6, https://doi.org/10.1038/s42255-023-00756-4.
Snell, Jeremy A, et al. “The Drinking Water and Swimming Pool Disinfectant Trichloroisocyanuric Acid Causes Chlorination Stress Enhancing Solar UV-Induced Inflammatory Gene Expression in AP-1 Transgenic SKH-1 Luciferase Reporter Mouse Skin.”. Photochem Photobiol, vol. 99, no. 2, Mar. 2023, pp. 835-43, https://doi.org/10.1111/php.13675.
Ito, Hisakatsu, et al. “Chronic Pain Recruits Hypothalamic Dynorphin Kappa Opioid Receptor Signalling to Promote Wakefulness and Vigilance.”. Brain, vol. 146, no. 3, Jan. 2023, pp. 1186-99, https://doi.org/10.1093/brain/awac153.
Gabriel, Katherin A, and Streicher, John M. “HSP90 Inhibition in the Mouse Spinal Cord Enhances Opioid Signaling by Suppressing an AMPK-Mediated Negative Feedback Loop.”. Sci Signal, vol. 16, no. 780, Jan. 2023, p. eade2438, https://doi.org/10.1126/scisignal.ade2438.
Ashina, Sait, et al. “Medication Overuse Headache.”. Nat Rev Dis Primers, vol. 9, no. 1, Jan. 2023, p. 5, https://doi.org/10.1038/s41572-022-00415-0.
Schwarz, Abigail M, et al. “Terpenes from Induce Antinociception in Mouse Chronic Neuropathic Pain via Activation of Spinal Cord Adenosine A Receptors.”. BioRxiv, Jan. 2023, https://doi.org/10.1101/2023.03.28.534594.
Tanguturi, Parthasaradhireddy, and Streicher, John M. “The Role of Opioid Receptors in Modulating Alzheimer’s Disease.”. Front Pharmacol, vol. 14, Jan. 2023, p. 1056402, https://doi.org/10.3389/fphar.2023.1056402.
2022
Stanton, Joshua A, et al. “Targeting Organic Cation Transporters at the Blood-Brain Barrier to Treat Ischemic Stroke in Rats.”. Exp Neurol, vol. 357, Nov. 2022, p. 114181, https://doi.org/10.1016/j.expneurol.2022.114181.
Branigan, Gregory L, et al. “Age and Sex Differences on Anti-Hyperglycemic Medication Exposure and Risk of Newly Diagnosed Multiple Sclerosis in Propensity Score Matched Type 2 Diabetics.”. Heliyon, vol. 8, no. 10, Oct. 2022, p. e11196, https://doi.org/10.1016/j.heliyon.2022.e11196.
Navratilova, Edita, et al. “Preclinical Assessment of OnabotulinumtoxinA for the Treatment of Mild Traumatic Brain Injury-Related Acute and Persistent Post-Traumatic Headache.”. Cephalalgia, vol. 42, no. 11-12, Oct. 2022, pp. 1194-06, https://doi.org/10.1177/03331024221099841.
McLean, John W, et al. “Contributions of Sex and Genotype to Exploratory Behavior Differences in an Aged Humanized Mouse Model of Late-Onset Alzheimer’s Disease.”. Learn Mem, vol. 29, no. 9, Sept. 2022, pp. 321-3, https://doi.org/10.1101/lm.053588.122.
Ahmed, Tasmia, et al. “EPDR1 Is a Noncanonical Effector of Insulin-Mediated Angiogenesis Regulated by an Endothelial-Specific TGF-β Receptor Complex.”. J Biol Chem, vol. 298, no. 9, Sept. 2022, p. 102297, https://doi.org/10.1016/j.jbc.2022.102297.
Tang, Xin, et al. “Use of Oral Diabetes Medications and the Risk of Incident Dementia in US Veterans Aged ≥60 Years With Type 2 Diabetes.”. BMJ Open Diabetes Res Care, vol. 10, no. 5, Sept. 2022, https://doi.org/10.1136/bmjdrc-2022-002894.
Branigan, Gregory L, et al. “Androgen-Targeting Therapeutics Mitigate the Adverse Effect of GnRH Agonist on the Risk of Neurodegenerative Disease in Men Treated for Prostate Cancer.”. Cancer Med, vol. 11, no. 13, July 2022, pp. 2687-98, https://doi.org/10.1002/cam4.4650.
Betterton, Robert D, et al. “Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor- Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.E., Statins).”. Drug Metab Dispos, vol. 50, no. 7, July 2022, pp. 942-56, https://doi.org/10.1124/dmd.121.000781.
Starling, Amaal J, et al. “Cutaneous Heat and Light-Induced Pain Thresholds in Post-Traumatic Headache Attributed to Mild Traumatic Brain Injury.”. Headache, vol. 62, no. 6, June 2022, pp. 726-3, https://doi.org/10.1111/head.14318.
Ikegami, Daigo, et al. “A Prolactin-Dependent Sexually Dimorphic Mechanism of Migraine Chronification.”. Cephalalgia, vol. 42, no. 3, Mar. 2022, pp. 197-08, https://doi.org/10.1177/03331024211039813.
Mishra, Aarti, et al. “A Tale of Two Systems: Lessons Learned from Female Mid-Life Aging With Implications for Alzheimer’s Prevention & Treatment.”. Ageing Res Rev, vol. 74, Feb. 2022, p. 101542, https://doi.org/10.1016/j.arr.2021.101542.
Fullerton, Evan F, et al. “Age-Induced Changes in μ-Opioid Receptor Signaling in the Midbrain Periaqueductal Gray of Male and Female Rats.”. J Neurosci, vol. 42, no. 32, Jan. 2022, pp. 6232-42, https://doi.org/10.1523/JNEUROSCI.0355-22.2022.
Bruhns, Ryan P, et al. “Angiotensin-(1-7) Improves Cognitive Function and Reduces Inflammation in Mice Following Mild Traumatic Brain Injury.”. Front Behav Neurosci, vol. 16, Jan. 2022, p. 903980, https://doi.org/10.3389/fnbeh.2022.903980.
Keresztes, Attila, et al. “Antagonism of the Mu-Delta Opioid Receptor Heterodimer Enhances Opioid Antinociception by Activating Src and Calcium Calmodulin-Dependent Protein Kinase II Signaling.”. Pain, vol. 163, no. 1, Jan. 2022, pp. 146-58, https://doi.org/10.1097/j.pain.0000000000002320.
Torrandell-Haro, Georgina, et al. “Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients.”. Front Aging Neurosci, vol. 14, Jan. 2022, p. 878304, https://doi.org/10.3389/fnagi.2022.878304.